Back to Inositol (Myo-Inositol)

Timing & pharmacokinetics

How long does Inositol (Myo-Inositol) take to work?

Onset timing for Inositol (Myo-Inositol) varies in the clinical literature. Onset timing is not well-quantified in our dataset — refer to clinical citations on the main entry.

Onset

Half-life

Duration

Timing

with meals

Key facts

typical dose
2000–18000 mg
dose frequency
1-3 doses
timing
with meals
with food
with meal
safety score
5/5
evidence grade
A
class
neuroprotective
PubMed citations
3800
legal status (US)
Over-the-counter
legal status (UK)
Over-the-counter
legal status (EU)
Over-the-counter
legal status (AU)
Over-the-counter
primary mechanism
Functions as a precursor to phosphatidylinositol, a key second messenger system in intracellular signaling.

Onset window

Inositol (Myo-Inositol) onset times in the published literature vary widely. Refer to the citations on the main Inositol (Myo-Inositol) entry for compound-specific pharmacokinetic data.

Food effect: Taking with food slows absorption but improves tolerance. Onset shifts 30–60 minutes later than empty-stomach dosing.

Half-life and dosing frequency

Half-life is not characterised in our dataset.

Acute vs. chronic effect

Some nootropics work the first time you take them (Inositol (Myo-Inositol) may or may not). Others — adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways — require 2–4 weeks of daily dosing before the full effect emerges.

If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal — extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.

Protocol note from the Inositol (Myo-Inositol) entry

PCOS: 2-4g. Psychiatric: 12-18g.

Mechanism, safety, and citations for Inositol (Myo-Inositol) are on the main reference page — see Inositol (Myo-Inositol). For full dose protocol see Inositol (Myo-Inositol) dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.

Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.